Job Watch

Systematic Testing of Radionuclides in Preclinical Experiments (STRIPE) (R01 Clinical Trial Not Allowed)

Funding Opportunity PAR-22-139 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to solicit R01 research projects utilizing state-of-the-art cancer biology methods and model systems to study effects of different types of radiation used in radionuclide-based therapeutics (e.g., radiopharmaceutical therapy) on normal tissue, tumor cells and the tumor microenvironment.

Systematic Testing of Radionuclides in Preclinical Experiments (STRIPE) (R21 Clinical Trial Not Allowed)

Funding Opportunity PAR-22-140 from the NIH Guide for Grants and Contracts. The STRIPE program seeks to support pre-clinical research projects utilizing state-of-the-art cancer biology methods and model systems that study how radiopharmaceutical therapy (RPT) agents affect the biology of normal tissue, tumor cells and the tumor microenvironment. Ideally, proposed aims will be designed to test hypotheses on how RPT dynamically impacts cancer biology processes, which can serve as the pre-clinical basis for developing new targeting strategies and approaches. Studies supported by this PAR will ultimately inform the rationale and design of new RPT-based clinical trials.

EMBL: Science / Technical Officer - Bioinformatics Tools & Training

New Scientist - Bioinformatics - Fri, 2022-03-18 10:14
Competitive Salary: EMBL: ELIXIR is seeking an experienced bioinformatician who can combine technical understanding of current trends in bioinformatics software with experience Hinxton, Cambridgeshire, England
Categories: Job Watch

Findings of Research Misconduct

Notice NOT-OD-22-096 from the NIH Guide for Grants and Contracts

Findings of Research Misconduct

Notice NOT-OD-22-095 from the NIH Guide for Grants and Contracts

Findings of Research Misconduct

Notice NOT-OD-22-097 from the NIH Guide for Grants and Contracts

National Centers for Translational Research in Reproduction and Infertility (NCTRI) (P50) (Clinical Trial Optional)

Funding Opportunity RFA-HD-23-011 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to announce the re-competition of the National Centers for Translational Research in Reproduction and Infertility (NCTRI). The NCTRI will be administered through the Specialized Research Center (P50) award mechanism. These centers will form a national network that facilitates and accelerates bidirectional knowledge transfer between the laboratory and clinic with the ultimate goal of improving human reproductive health through research excellence and innovation.

Findings of Research Misconduct

Notice NOT-OD-22-098 from the NIH Guide for Grants and Contracts

CY Partners: Senior IVD Development Scientist

New Scientist - Bioinformatics - Wed, 2022-03-16 18:50
£30-60K: CY Partners: A very exciting opening for a Senior IVD Development Scientist has become available at a growing life sciences organisation, with R&D facilities in... Newcastle Upon Tyne, Tyne and Wear (GB)
Categories: Job Watch

Scientist 2-Emerging Applications - Illumina - Madison, WI

Indeed.com - Bioinformatics - Wed, 2022-03-16 14:17
Experience with various analysis tools for next-generation sequencing analysis highly desirable. Experienced in molecular biology methods for nucleic acid…
From Illumina - Wed, 16 Mar 2022 18:17:10 GMT - View all Madison, WI jobs
Categories: Job Watch

NIDDK Partnerships with Professional Societies to Enhance Scientific Workforce Diversity and Promote Scientific Leadership (R25 - Clinical Trial Not Allowed)

Funding Opportunity RFA-DK-22-004 from the NIH Guide for Grants and Contracts. This R25 program encourages professional societies supporting the NIDDK mission areas to develop educational programs aimed at recruiting talented fellows and junior faculty from diverse backgrounds, including those groups underrepresented in biomedical, behavioral, clinical, and social sciences research. Professional societies should propose an educational program that includes a diversity management plan that would enhance the diversity of the organization's scientific workforce and the pool of individuals from groups historically marginalized andunderrepresented in the organization's programs and leadership.

Wellcome Sanger Institute: Senior Bioinformatician - CRISPR Gene Editing

New Scientist - Bioinformatics - Wed, 2022-03-16 05:22
£38,500 - £46,500 per annum: Wellcome Sanger Institute: Here at the world-famous and internationally respected Wellcome Sanger Institute, we have an exciting opportunity for a motivated Senior Bioinforma... Cambridge, Cambridgeshire (GB)
Categories: Job Watch

KUH Predoctoral to Postdoctoral Fellow Transition Award (F99/K00 - Independent Clinical Trial Not Allowed)

Funding Opportunity RFA-DK-21-033 from the NIH Guide for Grants and Contracts. The purpose of the Kidney, Urology or Hematology (KUH) Predoctoral to Postdoctoral Fellow Transition Awards (F99/K00) is to recruit exceptional graduate students from diverse research fields to pursue postdoctoral training focused on Kidney, Urology or Hematology (K, U, or H) research. Talented graduate students from disciplines including, but not limited to, engineering, statistics, data science, imaging, biochemistry and genetics are invited to apply to this opportunity. Graduate students who are already involved in K, U, or H research are not eligible for the F99/K00 award and are instead encouraged to apply for the Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship (Parent F31, PA-19-195). Prospective applicants are strongly encouraged to contact the NIDDK Program Official prior to initiating plans for application submission. This Funding Opportunity Announcement (FOA) does not allow applicants to propose to lead an independent clinical trial, but does allow applicants to propose research experience in a clinical trial led by a sponsor or co-sponsor.

Pages

Subscribe to Anil Jegga aggregator - Job Watch